As Health-Care IPO Boom Continues, Wall Street Tells Investors to Buy
This article is for subscribers only.
Health-care companies are going public at a startling rate and analysts are as bullish as ever as they kick off initiations of five companies today.
The companies range from one developing so-called “off the shelf” immunotherapies to a commercial-stage medical device maker with a non-invasive treatment for depression. Even as two of the five companies have slid from their initial valuations, only one company has so far earned anything less than a buy from the analysts who underwrote the deals.